2028 年心脏代谢疾病市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00025374
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 293
Buy Now

心脏代谢疾病市场规模预计将从 2021 年的 934.9441 亿美元增至 2028 年的 1218.0449 亿美元;预计 2021-2028 年期间的复合年增长率为 3.9%。

心脏代谢疾病的特征是一组异常和症状,这些异常和症状会增加个人患心血管疾病的风险。高血压、肥胖、胰岛素抵抗、血脂异常、胆固醇水平低下 (LDL) 和葡萄糖耐受性差是心脏代谢疾病的一些症状。患有心脏代谢综合征的人容易患上许多其他危及生命的疾病,例如 2 型糖尿病、中风、冠状动脉疾病 (CAD) 和心血管疾病 (CVD)。遗传和环境条件都是导致疾病发展的原因。

 

心脏代谢疾病市场的增长主要归因于心脏代谢疾病患病率的上升和 CMD 疗法的创新等因素。然而,中低收入国家 (LMIC) 的心血管疾病诊断不足阻碍了市场的增长。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

心脏代谢疾病市场:

Cardiometabolic Diseases Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

市场洞察
心脏代谢疾病患病率不断上升

心脏代谢疾病 (CMD) 是全球主要死亡原因之一。这些疾病主要由不健康的生活方式、缺乏运动、吸烟和不健康的饮食引起。CMD 包括心血管疾病 (CVD)、糖尿病和慢性肾衰竭。根据世界卫生组织的数据,2019 年约有 1790 万人死于心血管疾病,占全球死亡人数的 32%。在这些死亡中,85% 是由于心脏病发作和中风。

大多数心血管疾病可以通过解决行为风险因素来预防,例如吸烟、不健康的饮食选择、肥胖、缺乏运动和饮酒。糖尿病是一种危及生命的慢性疾病,目前尚无功能性治愈方法。它会导致各种并发症,并增加过早死亡的总体风险。心脏病发作、中风、肾衰竭、截肢、视力丧失和神经损伤是与糖尿病相关的主要并发症。根据国际糖尿病联合会 (IDF) 的数据,2019 年,约有 4.63 亿成年人患有糖尿病,预计到 2045 年将达到 7 亿。

由于吸烟、缺乏运动、饮酒和不健康的饮食习惯增加,全球患有一种或多种 CMD 的人数正在增加。根据世界卫生组织 2021 年 7 月的统计数据,每年有超过 800 万人死于吸烟。烟草消费在中低收入国家较高,全球 80% 的烟草消费群体生活在这些国家。肥胖症的日益流行也导致患者群体患有 CMD。随着 CMD 患病率的迅速上升,对适当的心脏代谢疾病治疗的需求急剧上升,导致市场大幅增长。

基于类型的洞察

心脏代谢疾病市场按类型分为心血管疾病 (CVD)、高血压、2 型糖尿病和肥胖症。心血管疾病 (CVD) 细分市场在 2021 年占据了最大的市场份额,预计该细分市场在预测期内将实现最高的复合年增长率。

基于治疗的见解

根据治疗,心脏代谢疾病市场分为 ACE 抑制剂、利尿剂、格华止等。ACE 抑制剂细分市场在 2021 年占据了最大的市场份额,预计该细分市场在预测期内将实现最高的复合年增长率。

基于剂量的见解

心脏代谢疾病市场按剂量分为片剂和注射剂。片剂部分在 2021 年占据了更大的市场份额,预计在预测期内市场复合年增长率将更高。

基于给药途径的见解

心脏代谢疾病市场按给药途径分为口服和静脉注射。2021 年,口服药物占据了更大的市场份额,预计未来几年的复合年增长率将更高。

基于最终用户的洞察

根据最终用户,心脏代谢疾病市场分为诊所、医院和家庭护理环境。2021 年,医院部门占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。


产品发布和审批是企业扩大全球影响力和产品组合的常用策略。此外,实验室开发的测试市场参与者专注于合作策略来扩大客户群,这反过来又使他们能够在全球范围内维护自己的品牌名称。

报告将心脏代谢疾病市场细分如下

根据类型,心脏代谢疾病市场细分为心血管疾病 (CVD)、高血压、2 型糖尿病和肥胖症。根据治疗方法,市场细分为 ACE 抑制剂、利尿剂、格华止等。根据剂量,心脏代谢疾病市场分为片剂和注射剂。根据给药途径,市场分为口服和静脉注射。根据最终用户,心脏代谢疾病市场细分为诊所、医院和家庭护理环境。按地域划分,市场细分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚、韩国和亚太其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

 

心脏代谢疾病市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响心脏代谢疾病市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的心脏代谢疾病市场细分和地理位置。

Cardiometabolic Diseases Market
  • 获取心脏代谢疾病市场的区域特定数据

心脏代谢疾病市场报告范围

报告属性细节
2021 年市场规模934.9亿美元
2028 年市场规模1218亿美元
全球复合年增长率(2021 - 2028)3.9%
史料2019-2020
预测期2022-2028
涵盖的领域按类型
  • 心血管疾病
  • 2 型糖尿病
  • 高血压
  • 肥胖
按治疗
  • 血管紧张素转换酶 (ACE) 抑制剂
  • 利尿剂
  • 格华止
按剂量
  • 药片
  • 注射
按给药途径
  • 口服
  • 静脉
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 礼来公司
  • 拜耳公司
  • Arrowhead Pharmaceuticals, Inc
  • 诺华公司
  • 勃林格殷格翰国际有限公司
  • 诺和诺德公司
  • 阿斯利康
  • Alnylam 制药公司
  • Cardax 公司

市场参与者密度:了解其对商业动态的影响

心脏代谢疾病市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在心脏代谢疾病市场运营的主要公司有:

  1. 礼来公司
  2. 拜耳公司
  3. Arrowhead Pharmaceuticals, Inc
  4. 诺华公司
  5. 勃林格殷格翰国际有限公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Cardiometabolic Diseases Market

 

  • 了解心脏代谢疾病市场顶级关键参与者概况

 

公司简介

  • 礼来公司
  • 拜耳公司
  • Arrowhead Pharmaceuticals, Inc
  • 诺华公司
  • 勃林格殷格翰国际有限公司
  • 诺和诺德公司
  • 阿斯利康
  • Alnylam 制药公司
  • Cardax 公司
  • 兴和株式会社
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the cardiometabolic diseases market?

The global cardiometabolic diseases market cardiovascular disease (CVD), hypertension, type 2 diabetes, and obesity. The cardiovascular disease (CVD) segment is expected to hold the largest share and register the highest CAGR in the market during the forecast period.

Who are the major players in the cardiometabolic diseases market?

The cardiometabolic diseases market majorly consists of the players such as as Eli Lilly and Company; Bayer AG; Arrowhead Pharmaceuticals, Inc; Novartis AG; Boehringer Ingelheim International GmbH; Novo Nordisk A/S; AstraZeneca; Alnylam Pharmaceuticals, Inc.; Cardax, Inc.; and Kowa Company, Ltd among others.

What are the driving factors for the cardiometabolic diseases market across the country?

The factors that are driving and restraining factors that will affect cardiometabolic diseases market in the coming years. Factors such as increasing prevalence of cardiometabolic diseases and innovation in CMDs therapeutics. However, underdiagnosis of CVDs in low- and middle-income countries (LMICs) is hampering the growth of the market.

What is cardiometabolic diseases market?

Cardiometabolic disease is characterized by a group of abnormalities and symptoms that raise the risk of individuals developing cardiovascular disease. Hypertension, obesity, insulin resistance, dyslipidemia, poor cholesterol profile (LDL), and glucose tolerance are a few symptoms of cardiometabolic diseases. Individuals suffering from cardiometabolic syndrome are prone to many other life-threatening diseases, such as type 2 diabetes, stroke, coronary artery disease (CAD), and cardiovascular disease (CVD). Both genetic and environmental conditions are responsible for the development of the diseases.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Cardiometabolic Diseases Market

  1. Eli Lilly and Company
  2. Bayer AG
  3. Arrowhead Pharmaceuticals, Inc
  4. Novartis AG
  5. Boehringer Ingelheim International GmbH
  6. Novo Nordisk A/S
  7. AstraZeneca
  8. Alnylam Pharmaceuticals, Inc.
  9. Cardax, Inc
  10. Kowa Company, Ltd.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.